A recent paper describes TCS in five out of nine patients with a mutation at site C342 (Wenger et al., 2016), supporting our hypothesis that homozygous FGFR2-C342Y mice mimic severe features associated with heterozygote CPS patients and that screening for this condition in CPS patients should be considered. Here, FGFR2 is linked to Treacher-Collins syndrome.